CI
CDMO

Cooper Investors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Cooper Investors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-134,400
Closed -$874K – 46
2023
Q4 		$874K Buy
+134,400
New +$866K 0.05% 42

Other funds holding CDMO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Cooper Investors's CDMO Position: Q1 2024 in Review

Cooper Investors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2024, closing a stake of 134,400 shares — an estimated $874K sold.

Cooper Investors first reported a position in CDMO in Q4 2023 and held it in 1 quarter. The position peaked at $874K in Q4 2023. 166 funds tracked by Wall St. Rank hold CDMO as of Q1 2024.

  • Cooper Investors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Cooper Investors sold 134,400 Avid Bioservices, Inc. Common Stock shares in Q1 2024, an estimated $874K.
  • Cooper Investors first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Cooper Investors's Avid Bioservices, Inc. Common Stock position peaked at $874K in Q4 2023.
  • 166 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2024.

Based on Cooper Investors's 13F filing for Q1 2024, filed 10 Apr 2025.